靶向细胞表面膜抗原的抗体在慢性移植物抗宿主病患者中的研究
该研究探讨慢性移植物抗宿主病(cGVHD)患者移植后针对多种cGVHD受累组织中表达的细胞表面抗原的免疫球蛋白G抗体的产生。使用板结合细胞膜蛋白作为靶标,发现发生cGVHD的患者中与这些膜抗原反应的抗体水平显著高于未发生cGVHD的患者和健康供者。血浆反应性抗体水平在cGVHD临床诊断前显著升高,并在包括泼尼松、白细胞介素-2或体外光泳疗法在内的cGVHD治疗后降低。通过基于细胞的免疫沉淀和质谱分析,鉴定出43种被这些抗体靶向的膜蛋白,并验证了其中6种蛋白的特异性抗体在cGVHD患者血浆中更频繁地检出。
要点
- cGVHD患者中针对细胞膜抗原的抗体水平显著高于无cGVHD患者和健康供者
- 血浆反应性抗体水平在cGVHD临床诊断前显著升高,治疗后降低
- 鉴定出43种靶向膜蛋白,验证了其中6种在cGVHD患者中更频繁检出
核心结论
- 靶向活细胞膜抗原的抗体在cGVHD患者中频繁产生,进一步支持B细胞和抗体在cGVHD发展中的作用。
研究设计与样本
- 研究聚焦于移植后针对多种cGVHD受累组织中表达的细胞表面抗原的免疫球蛋白G抗体的产生,使用板结合细胞膜蛋白作为靶标,并采用基于细胞的免疫沉淀与质谱分析。
主要发现
- 发生cGVHD的患者中与膜抗原反应的抗体水平显著高于未发生cGVHD的患者和健康供者。
- 血浆反应性抗体水平在cGVHD临床诊断前显著升高,并在包括泼尼松、白细胞介素-2或体外光泳疗法在内的cGVHD治疗后降低。
- 鉴定出43种被这些抗体靶向的膜蛋白,并验证了其中6种蛋白的特异性抗体在cGVHD患者血浆中更频繁地检出。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplant reflects a complex immune response resulting in chronic damage to multiple tissues. Previous studies indicated that donor B cells and the antibodies they produce play an important role in the development of cGVHD. To understand the pathogenic role of antibodies in cGVHD, we focused our studies on posttransplant production of immunoglobulin G antibodies targeting cell surface antigens expressed in multiple cGVHD affected tissues, due to their potential functional impact on living cells in vivo. Using plate-bound cell membrane proteins as targets, we detected a significantly higher level of antibodies reactive with these membrane antigens in patients who developed cGVHD, compared with those who did not and healthy donors. Plasma-reactive antibody levels increased significantly prior to the clinical diagnosis of cGVHD and were reduced following cGVHD therapies including prednisone, interleukin-2, or extracorporeal photophoresis. Using cell-based immunoprecipitation with plasma from cGVHD patients and mass spectrometry, we identified 43 membrane proteins targeted by these antibodies. The presence of antibodies in cGVHD patients' plasma that specifically target 6 of these proteins was validated. Antibodies reactive with these 6 antigens were more frequently detected in patients with cGVHD compared with patients without cGVHD and healthy donors. These results indicate that antibodies that target membrane antigens of living cells frequently develop in cGVHD patients and further support a role for B cells and antibodies in the development of cGVHD.
引用
- Wang KS, Kim HT, Nikiforow S, et al. Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease. Blood. 2017. PMID: 29138220. doi:10.1182/blood-2017-08-801001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。